Zicam Swab Platform Takes Center Stage In Matrixx Growth Plans

Matrixx Initiatives plans to introduce more products delivered via the swab platform used in one of the Zicam nasal products that FDA advised the firm to recall in 2009

More from Archive

More from Pink Sheet